Abstract | BACKGROUND: MATERIAL AND METHODS: Cryostat sections of 51 primary HNSCC were immunostained for VEGF and bFGF using a standard streptavidin- biotin complex procedure. To evaluate angiogenesis, endothelial cells were stained immunohistochemically using anti-vWF polyclonal antibody. Microvessels were quantified by counting vessels in a x200 field in the most vascular area of the tumor. RESULTS: 25/51 (49%) of the investigated carcinomas showed co-expression of both factors ( VEGF+/bFGF+), while 6/51 (11.7%) carcinomas only expressed VEGF and 13/51 (25.5%) carcinomas expressed bFGF. 7/51 (13.7%) tumors showed no expression of these factors ( VEGF-/bFGF-). Carcinomas with a co-expression of VEGF and bFGF showed a significantly increased mean microvessel density (88.3 +/- 24.4) compared to tumors expressing only VEGF (77 +/- 16.8) or bFGF (71.1 +/- 15.8) (p = 0.022) or tumors with no expression of both factors (51.1 +/- 13.4) (p < 0.001). The association of VEGF and bFGF expression level was not significant (p = 0.178). CONCLUSIONS: The positive correlation of the co-expression of angiogenic VEGF and bFGF with increased microvessel density underlines the importance of both factors for tumor angiogenesis in HNSCC. VEGF and bFGF might act cooperatively in the process of neovascularization in human head and neck cancer.
|
Authors | F Riedel, K Götte, J Schwalb, W Bergler, K Hörmann |
Journal | Laryngo- rhino- otologie
(Laryngorhinootologie)
Vol. 79
Issue 12
Pg. 730-5
(Dec 2000)
ISSN: 0935-8943 [Print] Germany |
Vernacular Title | Ko-Expression von VEGF und bFGF ist assoziiert mit einer erhöhten Gefässdichte in Kopf-Hals-Karzinomen. |
PMID | 11199455
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Endothelial Growth Factors
- Lymphokines
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
- Fibroblast Growth Factor 2
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Squamous Cell
(blood supply, pathology)
- Endothelial Growth Factors
(analysis)
- Endothelium, Vascular
(pathology)
- Female
- Fibroblast Growth Factor 2
(analysis)
- Humans
- Lymphokines
(analysis)
- Male
- Microcirculation
(pathology)
- Middle Aged
- Neoplasm Staging
- Neovascularization, Pathologic
(pathology)
- Otorhinolaryngologic Neoplasms
(blood supply, pathology)
- Prognosis
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
|